Real-World Evidence Steering Committee

Thank You to the Real-World Evidence Steering Committee

We would like to offer a sincere thank you to the Real-World Evidence (RWE) Steering Committee for providing strategic advice and support on cutting-edge topics related to the use and/or development of real-world data (RWD) and RWE for regulatory studies. From 2013 to 2024, committee members identified potential synergies between the Foundation and other data/technology, government, academic, and health sector organizations engaged in the use and/or development of RWD and RWE. Their guidance has enabled us to grow our programs – and for that we are eternally grateful!

Real-World Evidence Steering Committee Members

Ryan Kilpatrick, PhD
Vice President, Epidemiology
Global Epidemiology
AbbVie

Aaron Mendelsohn, PhD, MPH  (Non-voting)
Principal Research Scientist 
Harvard Pilgrim Health Care Institute

Vinit Nair, BPharm, MS, RPh
Chief Strategy Officer 
PRACnet

Christian Nguyen, PharmD, MBA, MS 
Senior Vice President of Value Evidence Outcomes 
Eli Lilly and Company

Sara Tartof, PhD, MPH 
Research Scientist, Epidemiologic Research 
Kaiser Permanente Southern California

FDA Representative (Non-voting)

Peter Marks, MD, PhD 
Director of the Center for Biologics Evaluation and Research (CBER)
Food and Drug Administration